🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: the Quadrivalent Vaccine (Gardasil)

Found 101 matching trials

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

PHASE4

The Gardasil vaccine, a vaccine targeted towards the human papillomavirus (...

Status

Completed

Location

Mayo Clinic

Start Date

2010-02

Trial ID

NCT01034358

Treatments Being Tested

Human Papillomavirus Vaccine

The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru

PHASE1

This project will use a community based participatory research orientation ...

Status

Completed

Location

Centro de Salud Portada de Manchay

Start Date

2011-05

Trial ID

NCT01338051

Treatments Being Tested

Gardasil

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

PHASE3

This study is designed to evaluate the vaccine efficacy, immunogenicity and...

Status

Recruiting

Location

Liuzhou center for disease control and prevention

Start Date

2020-04-28

Trial ID

NCT04422366

Treatments Being Tested

9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)GARDASIL®

Impact of HPV Vaccine On The Prevalence Of HPV In Norway

N/A

The overall aim of the study is to assess the effect of school-based Human ...

Status

Completed

Location

Oslo University Hospital, Cancer Registry of Norway

Start Date

2016-11

Trial ID

NCT02934724

Treatments Being Tested

Self sample from vagina Self sample from the oral cavity Questionnaire

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

PHASE3

The purpose of this study is to evaluate the immunogenicity and the safety ...

Status

Completed

Location

GSK Investigational Site

Start Date

2011-11-21

Trial ID

NCT01462357

Treatments Being Tested

Cervarix Gardasil Placebo

Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years

PHASE3

Human papillomavirus (HPV) infection is the most common viral infection of ...

Status

Active Not Recruiting

Location

Centre For Clinical Research, Kemri

Start Date

2025-10-03

Trial ID

NCT06281119

Treatments Being Tested

Cervavac as three dose regimen Cervavac as two dose regimen Gardasil as three dose regimen

Immune Memory After Papillomavirus Vaccination

N/A

Vaccines for human papillomavirus (HPV) have been available in the United S...

Status

Completed

Location

Emory University

Start Date

2012-01

Trial ID

NCT01505049

Treatments Being Tested

quadrivalent HPV vaccine

Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)

PHASE2

This study was conducted in 2 parts. Part A was a randomized, double-blind,...

Status

Completed

Location

Multiple Locations

Start Date

2000-05

Trial ID

NCT00365716

Treatments Being Tested

Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20 Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40 Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80 Placebo (mcg) (Aluminum Adjuvant)225 Placebo (mcg) (Aluminum Adjuvant) 450

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

PHASE3

The primary purpose of the study is to determine if an investigational vacc...

Status

Completed

Location

Multiple Locations

Start Date

2002-12

Trial ID

NCT00092495

Treatments Being Tested

V501, Gardasil, human papillomavirus (type 6, 11, 16, 18) recombinant vaccine

A Study to Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

PHASE3

This study is designed to evaluate the immunogenicity, safety, and tolerabi...

Status

Completed

Location

Yangchun Center For Disease Prevention And Control ( Site 0003)

Start Date

2018-08-31

Trial ID

NCT03493542

Treatments Being Tested

V501

Previous Next